This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Darque, A.
Right arrow Articles by Zhou, X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Darque, A.
Right arrow Articles by Zhou, X.-J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 1999, p. 2245-2250, Vol. 43, No. 9
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Quantitation of Intracellular Triphosphate of Emtricitabine in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Patients

Albert Darque,1 Gilles Valette,1 Frank Rousseau,2 Laurene H. Wang,2 Jean-Pierre Sommadossi,1,* and Xiao-Jian Zhou1

Department of Clinical Pharmacology, The Liver Center, Center for AIDS Research, University of Alabama at Birmingham, Birmingham, Alabama 35294,1 and Triangle Pharmaceuticals, Inc., Durham, North Carolina 277072

Received 25 March 1999/Returned for modification 24 May 1999/Accepted 1 July 1999

An analytical methodology combining solid-phase extraction (SPE) and high-performance liquid chromatography (HPLC) was developed to quantitate the intracellular active 5'-triphosphate (TP) of beta -L-2',3'-dideoxy-5-fluoro-3'-thiacytidine (emtricitabine) (FTC) in human peripheral blood mononuclear cells (PBMCs). The FTC nucleotides, including 5'-mono-, di-, and triphosphates, were successively resolved on an anion-exchange SPE cartridge by applying a gradient of potassium chloride. The FTC-TP was subsequently digested to release the parent nucleoside that was finally analyzed by HPLC with UV detection (HPLC-UV). Validation of the methodology was performed by using PBMCs from healthy donors exposed to an isotopic solution of [3H]FTC with known specific activity, leading to the formation of intracellular FTC-TP that was quantitated by an anion-exchange HPLC method with radioactive detection. These levels of FTC-TP served as reference values and were used to validate the data obtained by HPLC-UV. The assay had a limit of quantitation of 4.0 pmol of FTC-TP (amount on column from approximately 107 cells). Intra-assay precision (coefficient of variation percentage of repeated measurement) and accuracy (percentage deviation of the nominal reference value), estimated by using quality control samples at 16.2, 60.7, and 121.5 pmol, ranged from 1.3 to 3.3% and -1.0 to 4.8%, respectively. Interassay precision and accuracy varied from 3.0 to 10.2% and from 2.5 to 6.7%, respectively. This methodology was successfully applied to the determination of FTC-TP in PBMCs of patients infected with human immunodeficiency virus after oral administration of various dosing regimens of FTC monotherapy.

* Corresponding author. Mailing address: Department of Clinical Pharmacology, University of Alabama at Birmingham, Box 600, Volker Hall G019, University Station, Birmingham, AL 35294-0019. Phone: (205) 934-8226. Fax: (205) 975-4871. E-mail: Jean-Pierre.Sommadossi{at}CCC.UAB.EDU.

Antimicrobial Agents and Chemotherapy, September 1999, p. 2245-2250, Vol. 43, No. 9
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Modrzejewski, K. A, Herman, R. A (2004). Emtricitabine: A Once-Daily Nucleoside Reverse Transcriptase Inhibitor. The Annals of Pharmacotherapy 38: 1006-1014 [Abstract] [Full Text]  
  • Piliero, P. J. (2003). Early Factors in Successful Anti-HIV Treatment. J Int Assoc Physicians AIDS Care (Chic Ill) 2: 10-20 [Abstract]  
  • Gish, R. G., Leung, N. W. Y., Wright, T. L., Trinh, H., Lang, W., Kessler, H. A., Fang, L., Wang, L. H., Delehanty, J., Rigney, A., Mondou, E., Snow, A., Rousseau, F. (2002). Dose Range Study of Pharmacokinetics, Safety, and Preliminary Antiviral Activity of Emtricitabine in Adults with Hepatitis B Virus Infection. Antimicrob. Agents Chemother. 46: 1734-1740 [Abstract] [Full Text]  
  • Schinazi, R. F., Mellors, J., Bazmi, H., Diamond, S., Garber, S., Gallagher, K., Geleziunas, R., Klabe, R., Pierce, M., Rayner, M., Wu, J.-T., Zhang, H., Hammond, J., Bacheler, L., Manion, D. J., Otto, M. J., Stuyver, L., Trainor, G., Liotta, D. C., Erickson-Viitanen, S. (2002). DPC 817: a Cytidine Nucleoside Analog with Activity against Zidovudine- and Lamivudine-Resistant Viral Variants. Antimicrob. Agents Chemother. 46: 1394-1401 [Abstract] [Full Text]  
  • Rousseau, F. S., Kahn, J. O., Thompson, M., Mildvan, D., Shepp, D., Sommadossi, J.-P., Delehanty, J., Simpson, J. N., Wang, L. H., Quinn, J. B., Wakeford, C., van der Horst, C. (2001). Prototype trial design for rapid dose selection of antiretroviral drugs: an example using emtricitabine (Coviracil). J Antimicrob Chemother 48: 507-513 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»